Advancements in RNAi Therapeutics | 2024-2025 Update for Investors in Hospitals and Healthcare
RNA interference (RNAi) therapeutics have garnered significant attention due to their innovative approach in treating a range of diseases. As of 2025, this sector is evolving rapidly, with numerous advancements that have the potential to reshape the landscape of healthcare.
Alternative Title
RNAi Therapeutics Market Growth 2024-2025 | Alnylam's Vutrisiran, Arrowhead's Plozasiran, Roche's Strategic Deals, and Investment Trends in Hospitals & Healthcare